hsa-miR-20a

ncRNA information

ncRNA name

hsa-miR-20a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

iASPP

Downstream target

FBXL5/BTG3

Cancer information

Cancer name

Cervical Cancer

Cancer site

Cervix Uteri

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Overexpression of miR-20a significantly decreased the activity of cisplatin by restoring cell survival.

Tissue resource

pairs of primary CC specimens and adjacent non-tumor cervical tissues

cervical cancer cell lines HeLa

cervical cancer cell lines SiHa

human embryonic kidney cell lines HEK-293T

human normal endometrial epithelial cell lines EM

Experiment

qRT-PCR,Western blot


Institute

Sun Yat-Sen University Cancer Center

American Type Culture Collection

Country

China

USA

Continent

Asia

Amercia